Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 8 de 8
Filter
1.
Article in English | IMSEAR | ID: sea-145368

ABSTRACT

Background & objectives: Medicines can account for up to 90 per cent of health care spending by poor people. High costs of medicines contribute to decreased access to healthcare. This study was conducted to assess the cost of medicines and their affordability in the private pharmacies in Delhi, India. Methods: A survey was conducted to assess the costs of prescribed medicines and treatment of community acquired pneumonia (CAP), with medicines purchased from 27 private pharmacies, in Delhi. Affordability of medicines was assessed by comparing the costs of treatment (medicines) to the monthly per capita expenditure (MPCE) on food, minimum monthly and daily wages for different classes of workers. Results: A large variability in the costs of prescriptions was observed (129.37+ 217.99) The cost of treatment of CAP varied from 34.50- 244.75 with azithromycin and 72.20- 277.30 with levofloxacin. The percentage of MPCE on food spent for a prescription was 17.64 per cent for urban and 23.4 per cent for rural population. The percentage of MPCE on food spent for treatment of CAP ranged from 10.11 to 13.42 per cent with azithromycin and 13.28 to 17.61 per cent with levofloxacin. The number of days a worker on minimum daily wages would have to work to enable him to purchase his prescription medicines ranged from 1-17 days, depending on the problem. The cost of treatment of CAP required 1-3 days of work by a daily wage earner, depending on the brand of medicine prescribed. Interpretation & conclusions: The findings of our study show that the costs of medicines are highly variable and not affordable for the economically poor in India. Modifications in National Pharmaceutical Policy need to be done urgently.


Subject(s)
Drug Costs/trends , Drug Costs/statistics & numerical data , Humans , India , Pharmacies/economics , Pharmacies/supply & distribution , Pharmaceutical Preparations/economics , Pharmaceutical Preparations/supply & distribution , Pneumonia/drug therapy
2.
Rev. saúde pública ; 46(3): 583-586, jun. 2012.
Article in English | LILACS | ID: lil-625670

ABSTRACT

This paper discusses the key role played by public research institutes for promoting socioeconomic inclusion of local communities based on traditional knowledge and traditional medicine. Nongovernmental organizations and cooperatives have had an important role in raising financial resources, being involved with advocacy of local communities and advancing legislation changes. But strict best manufacturing practices regulations imposed by the Brazilian National Health Surveillance Agency on the requirements for approval and commercialization of drugs based on herbal medicine products call for the involvement of strong public research institutes capable of supporting community-based pharmacies. Thus, public research institutes are pivotal as they can conduct scientific research studies to evidence the efficacy of herbal medicine products and help building the capacity of local communities to comply with current regulations.


O artigo mostra o papel desempenhado por institutos públicos de pesquisa no Brasil na promoção da inclusão socioeconômica de comunidades locais por meio do uso do conhecimento tradicional e da medicina popular. Organizações não-governamentais e cooperativas são importantes para angariar recursos, defender os interesses das comunidades locais e influenciar mudanças no ordenamento jurídico. Entretanto, exigências de cunho legal relacionadas às Boas Práticas de Fabricação e à necessidade de comprovação da eficácia de medicamentos, impostas pela Agência Nacional de Vigilância Sanitária, tendem a demandar a intervenção de um instituto público de pesquisa capaz de auxiliar tais comunidades na aprovação e comercialização de medicamentos produzidos a partir de plantas medicinais. Assim, institutos públicos de pesquisa são essenciais para realizar estudos científicos que comprovem a eficácia das plantas medicinais e para auxiliar as comunidades locais a criarem a infraestrutura necessária para atender às exigências da Agência quanto a Boas Práticas de Fabricação.


Subject(s)
Humans , Academies and Institutes , Community Networks/organization & administration , Herbal Medicine/organization & administration , Knowledge , Pharmacies/organization & administration , Brazil , Community Networks/economics , Cooperative Behavior , Health Knowledge, Attitudes, Practice , Herbal Medicine/economics , Organizational Innovation , Pharmacies/economics , Residence Characteristics
3.
Rev. panam. salud pública ; 30(6): 586-591, Dec. 2011.
Article in Spanish | LILACS | ID: lil-612954

ABSTRACT

Objetivo. Describir el estado de la aplicación de la norma relacionada con la prohibición dela venta de antibióticos sin prescripción médica en farmacias de Bogotá, Colombia. Métodos. Estudio descriptivo transversal, en el cual se utilizó la técnica de simulación de compra en farmacias (droguerías) de Bogotá. La muestra de 263 farmacias se calculó con una precisión de 5% y un factor de corrección de 2% mediante estratificación (farmacias de cadenae independientes) y asignación aleatoria simple en cada estrato. Resultados. Del total de farmacias estudiadas, 80,3% no cumplen la norma que establecela venta de antibióticos con receta. En 20,1% de los casos, el expendedor indagó la edad del paciente o sus síntomas o ambos, con el fin de ofrecer otros medicamentos o para cambiar elantibiótico. En ninguna oportunidad se preguntó por antecedentes personales de alergia a los antibióticos. En los casos en los cuales hubo intención de venta del antibiótico, la presentación genérica fue la más comúnmente ofrecida (81,2%). Algunos expendedores de medicamentos hicieronrecomendaciones inapropiadas. Las localidades con mayor incumplimiento de la norma coinciden con aquellas que tienen altas tasas de necesidades básicas insatisfechas. Conclusiones. A cinco años de adopción de la norma orientada a contrarrestar la ventalibre de antibióticos, su cumplimiento es mínimo y la entrega no se realiza de acuerdo a los parámetros establecidos. El personal de farmacia no suministra la información requerida de acuerdo con sus competencias.


Objective. Describe the implementation status of a regulation prohibiting antibiotic sales without a medical prescription in pharmacies of Bogotá, Colombia. Methods. A cross-sectional descriptive study was conducted using the simulated purchase technique in Bogotá pharmacies (drugstores). The sample of 263 pharmacies was calculated by stratification (chain pharmacies and independent pharmacies) with 5% accuracy and a 2% correction factor. Simple randomization was assigned in eachstratum. Results. Out of the total pharmacies studied, 80.3% did not comply with the regulation established for prescription sales of antibiotics. In 20.1% of the cases, the dispenser asked about the patient’s age, symptoms, or both age and symptoms in order to offer other drugs or change the antibiotic. There were no inquiries about amedical history of allergy to antibiotics. In cases in which there was the intention to sell antibiotics, the generic format was most commonly offered (81.2%). Some drug dispensers made inappropriate recommendations. The locations with the highest levels of noncompliance with the regulation were also those with high rates of unmetbasic needs. Conclusions. Five years after passage of a regulation to halt the unrestricted sales of antibiotics, there is minimal compliance, and dispensing does not conform to the established parameters. Pharmacy personnel do not provide the required information according to their responsibilities.


Subject(s)
Adolescent , Adult , Humans , Middle Aged , Young Adult , Anti-Bacterial Agents/economics , Commerce/legislation & jurisprudence , Drug and Narcotic Control/legislation & jurisprudence , Pharmacies/legislation & jurisprudence , Colombia , Commerce/statistics & numerical data , Directive Counseling , Drug Prescriptions , Drug and Narcotic Control/economics , Drug and Narcotic Control/statistics & numerical data , Guideline Adherence/statistics & numerical data , Patient Education as Topic , Patient Simulation , Pharmacies/economics , Pharmacies/statistics & numerical data , Pharmacists/legislation & jurisprudence , Pharmacists/psychology , Pharmacists/statistics & numerical data , Pilot Projects , Sampling Studies , Truth Disclosure , Urban Health
4.
Rev. salud pública ; 13(2): 274-287, abr. 2011. tab
Article in Spanish | LILACS | ID: lil-602874

ABSTRACT

Objetivo Conocer las opiniones de los farmacéuticos con relación a los factores que explican la falta de visibilidad de la farmacia comunitaria como establecimiento sanitario y proponer estrategias de desarrollo profesional a fin de lograr mejorar la accesibilidad a los servicios profesionales mediante técnicas de investigación cualitativa. Material y métodos Se utilizó una Técnica de Grupo Nominal (TGN) en 2 rondas sucesivas, respondiendo a 2 consignas guía sobre factores y estrategias. Posteriormente se realizó un Framework analysis. Resultados Se aportaron 34 ideas referidas a factores y 32 a estrategias. Las estrategias fueron agrupadas en 14 temas, destacándose las vinculadas a la priorización de los servicios profesionales orientados a los pacientes, al cumplimiento de la ética y a la formación continua del farmacéutico. Discusión Las técnicas utilizadas permitieron evidenciar situaciones percibidas por los farmacéuticos que no están formalmente descriptas en la literatura. Aumentar la visibilidad de los servicios profesionales en las farmacias comunitarias implica acordar y abordar estrategias que deben sustentarse en la participación conjunta de los propios farmacéuticos, las asociaciones profesionales y las universidades.


Objective Ascertaining pharmacists' views related to factors explaining the lack of visibility of community pharmacies as being health facilities and proposing strategies for improving community pharmacy professional service accessibility using qualitative research techniques. Methods The nominal group technique (NGT) was used in two successive rounds using separate guidelines for factors and strategies. Framework analysis was then carried out. Results Thirty-four ideas related to "factors" and 32 related to "strategies" were obtained. Strategies were grouped into 14 topics, emphasising those prioritising patient-orientated professional services, ethical aspects and pharmacists' ongoing education. Discussion The techniques used led to identifying situations perceived by pharmacists which are not formally described in the literature. Raising awareness of professional services in community pharmacies implies agreeing on and developing strategies which should be based on joint participation by the pharmacists themselves, professional associations and universities.


Subject(s)
Humans , Community-Institutional Relations , Pharmacies , Argentina , Education, Pharmacy, Continuing , Focus Groups , Pharmacies/economics , Pharmacies/organization & administration , Public Opinion , Qualitative Research , Quality Improvement , Social Perception
6.
Rev. panam. salud pública ; 27(4): 291-299, abr. 2010. graf, tab
Article in English | LILACS | ID: lil-548484

ABSTRACT

Objectives: To assess the possibility of bias due to the limited target list and geographic sampling of the World Health Organization (WHO)/Health Action International (HAI) Medicine Prices and Availability survey used in more than 70 rapid sample surveys since 2001. Methods: A survey was conducted in Peru in 2005 using an expanded sample of medicine outlets, including remote areas. Comprehensive data were gathered on medicines in three therapeutic classes to assess the adequacy of WHO/HAI's target medicines list and the focus on only two product versions. WHO/HAI median retail prices were compared with average wholesale prices from global pharmaceutical sales data supplier IMS Health. Results: No significant differences were found in overall availability or prices of target list medicines by retail location. The comprehensive survey of angiotensin-converting enzyme inhibitor, anti-diabetic, and anti-ulcer products revealed that some treatments not on the target list were costlier for patients and more likely to be unavailable, particularly in remote areas. WHO/HAI retail prices and IMS wholesale prices were strongly correlated for higher priced products, and weakly correlated for lower priced products (which had higher estimated retailer markups). Conclusions: The WHO/HAI survey approach strikes an appropriate balance between modest research costs and optimal information for policy. Focusing on commonly used medicines yields sufficient and valid results. Surveyors elsewhere should consider the limits of the survey data as well as any local circumstances, such as scarcity, that may call for extra field efforts.


Objetivos: Evaluar la posibilidad de sesgo debido a la limitación de la lista de referencia y del muestreo geográfico de la encuesta de precios y disponibilidad de medicamentos de la Organización Mundial de la Salud/Health Action International (OMS/HAI) usada en más de 70 muestras de encuestas rápidas desde el 2001. Métodos: En el año 2005, se realizó una encuesta en Perú, con una muestra ampliada de puntos de venta de medicamento, incluso en zonas remotas. Se recogieron datos integrales acerca de los medicamentos de tres clases terapéuticas, con el fin de evaluar la idoneidad de la lista de referencia de medicamentos de la OMS/HAI y el énfasis únicamente en dos versiones del producto. Las medianas de los precios al por menor de la OMS/HAI se compararon con el promedio de precios al por mayor del proveedor de datos mundiales de ventas farmacéuticas IMS Health. Resultados: No se observó ninguna diferencia significativa en la disponibilidad general ni en los precios de los medicamentos de la lista de referencia por localización de venta al por menor. La encuesta integral de los inhibidores de la enzima convertidora de la angiotensina, los antidiabéticos y los productos antiulcerosos reveló que algunos tratamientos que no están en la lista destinataria eran más caros para los pacientes y era más probable que no estuvieran a la venta, sobre todo en las regiones remotas. Los precios al por menor de la OMS/HAI y los precios al por mayor de IMS presentaron una correlación intensa en el caso de los productos de precio más alto, y la correlación fue débil en el caso de los productos de precio más bajo (que tuvieron márgenes de beneficio calculados más altos para el minorista). Conclusiones: El método de la encuesta de la OMS/HAI logra un equilibrio adecuado entre los costos de investigación moderados y la información óptima para la política. El énfasis en los medicamentos de uso frecuente produce unos resultados válidos y suficientes. Los encuestadores de otros...


Subject(s)
Data Collection/methods , Fees, Pharmaceutical/statistics & numerical data , Pharmaceutical Preparations/economics , Angiotensin-Converting Enzyme Inhibitors/economics , Angiotensin-Converting Enzyme Inhibitors/supply & distribution , Anti-Infective Agents/economics , Anti-Infective Agents/supply & distribution , Anti-Ulcer Agents/economics , Anti-Ulcer Agents/supply & distribution , Anticonvulsants/economics , Anticonvulsants/supply & distribution , Drugs, Generic/economics , Drugs, Generic/supply & distribution , Hypoglycemic Agents/economics , Hypoglycemic Agents/supply & distribution , Peru , Pharmaceutical Preparations/supply & distribution , Pharmacies/classification , Pharmacies/economics , Pharmacies/statistics & numerical data , Public Sector/economics , Sampling Studies , World Health Organization
7.
Carta med. A.I.S. Boliv ; 11(1): 6-9, 1997. tab
Article in Spanish | LILACS | ID: lil-230572

ABSTRACT

El estudio muestra los resultados de una encuesta realizada en las ciudades de la Paz y El Alto, sobre comercializacion de sucedaneos de la leche materna (todo alimento comercializado o de otro modo presentado como substituto parcial o toal de la leche materna, sea o no adecuado para este fin) y alimentos complentarios (todo alimento manufacturado o preparado localmente, que convenga como complemento de la leche matrna o de las preparaciones para lactantes, cuando aquella o estas resulten insuficientes para satisfacer las necesidades nutricionales del lactante. Este tipo de alimento se suele llamar tambien "alimento de destete" o suplemento de la leche materna) en 78 farmacias de estas ciudades. Los encuestadores personificaron familiares con problemas para amamantar a su bebe, solicitando orientacion sobre acciones mas aconsejables. Preguntas tales como si es necesario visitar a un medico, suspender la lactancia materna, iniciar alimentacion con leche artificial o formula infantil, precio del sucedaneo, tiempo de administracion, producto aconsejado, edad de incio de alimentos complementarios al bebe, fueron planteadas. Se indago sobre el criterio de los responsables de farmacias sobre la utilidad o no de los estimulantes del apetito y/o vitaminas, las marcas de biberones (mamaderas) y chupones (tetinas), si ellos los recomiendan y si las leches maternizadas son saludables, sus desventajas y ventajas. Los resultados de estas interrogantes y otras se presentan y discusion en el presente articulo


Subject(s)
Breast-Milk Substitutes/adverse effects , Commerce/economics , Commerce/trends , Pharmacies/economics , Pharmacies/statistics & numerical data , Bolivia
SELECTION OF CITATIONS
SEARCH DETAIL